
Research area
Tissue Repair
Tendon, wound and connective-tissue models — and where human evidence is still missing.
Tissue Repair references
Research updates
Recent developments
The latest dated changes for tissue repair references. See all research updates.
HHS interim compounding policy
HHS published an enforcement-discretion policy covering BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 for licensed pharmacies and physicians. Comments close November 13, 2026.
Read the sourceOrthopaedic review
A JAAOS review of BPC-157, thymosin beta-4 and TB-500 finds mostly preclinical evidence.
Read the sourceFDA advisory committee votes
FDA’s Pharmacy Compounding Advisory Committee voted on seven peptides over July 23–24, recommending six and declining emideltide (DSIP).
Read the sourceCategory 2 removals
FDA announced the removal of 12 peptide substances from its Category 2 compounding list, effective about April 22, 2026. Removal is not approval.
Read the source

